Côte d’Ivoire
Overview
The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) began supporting HIV and AIDS care and treatment programs in Côte d’Ivoire in 2004.
Download Country Fact Sheet
Key Program Accomplishments
In fiscal year 2022, EGPAF in Côte d’Ivoire:

Tested 321,488 clients for HIV, of whom 6,979 were identified positive (2%)

Enrolled 7,512 new clients on ART, including 2,520 pregnant women

Provided ART to 75,893 clients

Performed 69,284 viral load tests; 94% of EGPAF clients are virally suppressed
Our Work

Solutions at Work
![]() |
AdvocacyEGPAF in Côte d’Ivoire advocates at the national level with the MSHPCMU to promote EGPAF’s global best practices to inform national implementation, such as differentiated service delivery initiatives; improve integration of regional work plans to ensure better coordination of the in-country response to HIV and AIDS; prioritize data quality management and systems at health care facilities; and strengthen access to functional laboratory equipment. Learn more about our global advocacy work. |
![]() |
ResearchOngoing and recent research and evaluation topics include viral load suppression in the context of differentiated service delivery, factors associated with death among patients on ART, the peer-led adolescent HIV group support model, COVID infection prevention and control, and pediatric dolutegravir (pDTG) resistance. Learn more about research at EGPAF. |